… and death in COVID-19 patients. Consequently, it is … cytokine storms promote the deterioration
of COVID-19. Here, we outline the pathophysiological processes through which cytokine …

… virus and the viral-mediated responses, in order to develop specific … COVID-19 patients.
Here, we review the current studies on two viral mediated-responses, specifically the cytokine …

… COVID-19 is associated with high levels of all four cytokines … that cytokine patterns are
predictive of COVID-19 survival and … Interestingly, the COVID-19-related cytokine response was …

… COVID-19 pulmonary immunopathology and describe the potential benefits or disadvantages
of IL-6 … drive systemic cytokine responses. Therefore, phase 3 studies based on elevated …

… As the authors state in their article, "lymphopenia as a biomarker of poor prognosis for
COVID-19 is not specific", we may question how IL-6 levels can be evaluated as specific factors …

… Measurement of IL-6 was our main evaluation criterion because its changes in the COVID-19 …
control to achieve optimal treatment response and outcome. The ability of PBM to decrease …

… to mount an adequate immune response to the virus, … cytokines, chemokines, and acute-phase
proteins. Indeed most IC patients with COVID-19 show high levels of cytokines (IL-1β, IL-6…

… While it is unclear why tocilizumab was chosen over anakinra in the early COVID-19
outbreak, we speculate that it may be because IL-6, unlike IL-1, is relatively easy to measure in …

… also plays a pivotal role in the management COVID-19 patients due to its ability to prevent …
that could modulate cytokines levels and play a part in the management of COVID-19. Several …

… The immune dysregulation in severe COVID-19 individuals was driven by IL-6 [12] and the
IL-6 … Therefore, IL-6 may be a potential target cytokine to treat COVID-19 related ARDS. IL-6 …